S 4152 · 117th Congress · Health

A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Introduced 2022-05-05· Sponsored by Sen. Kelly, Mark [D-AZ]· Senate

Bill Progress

✓
Introduced
2
Committee
3
Senate Vote
4
House
5
Enacted
Latest: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2022-05-05)

Plain Language Summary

[AI summary unavailable — showing source text] This bill reauthorizes through FY2027 the Food and Drug Administration's Critical Path Public-Private Partnerships, which support medical product innovation, development, and safety.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (2)

1 Democrat1 Republican
Sen. Collins, Susan M. [R-ME]ME
Sen. Sinema, Kyrsten [D-AZ]AZ